AngioDynamics Earnings Preview

AngioDynamics ANGO announces its next round of earnings this Thursday, January 07. Here is Benzinga's everything-that-matters guide for this Thursday's Q2 earnings announcement.

Net Income, Earnings, And Earnings Per Share

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Wall Street analysts see AngioDynamics reporting a loss of $0.02 per share on revenue of $67.35 million. AngioDynamics EPS in the same period a year ago totaled $0.06. Revenue was $70.00 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

The analyst consensus estimate would represent a 133.33% decline in the company's EPS figure. Revenue would be down 3.79% from the same quarter last year. AngioDynamics's reported EPS has stacked up against analyst estimates in the past like this:

Stock Performance

Shares of AngioDynamics were trading at $15.59 as of January 05. Over the last 52-week period, shares are up 5.32%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. AngioDynamics is scheduled to hold the call at 08:00:00 ET and can be accessed here.